65 research outputs found

    The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism.

    Get PDF
    International audienceAlthough multiple reports show that defective genetic networks underlie the aetiology of autism, few have translated into pharmacotherapeutic opportunities. Since drugs compete with endogenous small molecules for protein binding, many successful drugs target large gene families with multiple drug binding sites. Here we search for defective gene family interaction networks (GFINs) in 6,742 patients with the ASDs relative to 12,544 neurologically normal controls, to find potentially druggable genetic targets. We find significant enrichment of structural defects (P≤2.40E-09, 1.8-fold enrichment) in the metabotropic glutamate receptor (GRM) GFIN, previously observed to impact attention deficit hyperactivity disorder (ADHD) and schizophrenia. Also, the MXD-MYC-MAX network of genes, previously implicated in cancer, is significantly enriched (P≤3.83E-23, 2.5-fold enrichment), as is the calmodulin 1 (CALM1) gene interaction network (P≤4.16E-04, 14.4-fold enrichment), which regulates voltage-independent calcium-activated action potentials at the neuronal synapse. We find that multiple defective gene family interactions underlie autism, presenting new translational opportunities to explore for therapeutic interventions

    Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders.

    Get PDF
    International audienceRare copy-number variation (CNV) is an important source of risk for autism spectrum disorders (ASDs). We analyzed 2,446 ASD-affected families and confirmed an excess of genic deletions and duplications in affected versus control groups (1.41-fold, p = 1.0 × 10(-5)) and an increase in affected subjects carrying exonic pathogenic CNVs overlapping known loci associated with dominant or X-linked ASD and intellectual disability (odds ratio = 12.62, p = 2.7 × 10(-15), ∼3% of ASD subjects). Pathogenic CNVs, often showing variable expressivity, included rare de novo and inherited events at 36 loci, implicating ASD-associated genes (CHD2, HDAC4, and GDI1) previously linked to other neurodevelopmental disorders, as well as other genes such as SETD5, MIR137, and HDAC9. Consistent with hypothesized gender-specific modulators, females with ASD were more likely to have highly penetrant CNVs (p = 0.017) and were also overrepresented among subjects with fragile X syndrome protein targets (p = 0.02). Genes affected by de novo CNVs and/or loss-of-function single-nucleotide variants converged on networks related to neuronal signaling and development, synapse function, and chromatin regulation

    A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder

    Get PDF
    Autism spectrum disorder (ASD) is a highly heritable disorder of complex and heterogeneous aetiology. It is primarily characterized by altered cognitive ability including impaired language and communication skills and fundamental deficits in social reciprocity. Despite some notable successes in neuropsychiatric genetics, overall, the high heritability of ASD (~90%) remains poorly explained by common genetic risk variants. However, recent studies suggest that rare genomic variation, in particular copy number variation, may account for a significant proportion of the genetic basis of ASD. We present a large scale analysis to identify candidate genes which may contain low-frequency recessive variation contributing to ASD while taking into account the potential contribution of population differences to the genetic heterogeneity of ASD. Our strategy, homozygous haplotype (HH) mapping, aims to detect homozygous segments of identical haplotype structure that are shared at a higher frequency amongst ASD patients compared to parental controls. The analysis was performed on 1,402 Autism Genome Project trios genotyped for 1 million single nucleotide polymorphisms (SNPs). We identified 25 known and 1,218 novel ASD candidate genes in the discovery analysis including CADM2, ABHD14A, CHRFAM7A, GRIK2, GRM3, EPHA3, FGF10, KCND2, PDZK1, IMMP2L and FOXP2. Furthermore, 10 of the previously reported ASD genes and 300 of the novel candidates identified in the discovery analysis were replicated in an independent sample of 1,182 trios. Our results demonstrate that regions of HH are significantly enriched for previously reported ASD candidate genes and the observed association is independent of gene size (odds ratio 2.10). Our findings highlight the applicability of HH mapping in complex disorders such as ASD and offer an alternative approach to the analysis of genome-wide association data

    Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

    Get PDF
    Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

    Behavioral consequences and intervention of financial shocks

    No full text
    An increasing number of individuals report hardship to cover financial shortfalls, but most research to date examines expense shocks (e.g., a car repair) rather than income shocks (e.g., a one-time pay cut). Here we explore the behavioral consequences of expense and income shocks and propose a self-affirmation intervention to mitigate the psychological toll posed by financial shocks. In three experiments, participants were presented with a hypothetical financial emergency (i.e., a one-time income shock or expense shock) and answered questions afterwards. We found that income shocks evoked more methods of coping, were harder to cope with, more impactful on daily life, and perceived as more of a loss than expense shocks of the same amount. Self-affirmation as a behavioral intervention successfully mitigated some of the deleterious effects of the shocks. The findings contribute a more nuanced understanding of decision making in response to shortfalls by differentiating income and expense shocks. Our study suggests that there are psychological distinctions in how different financial shocks are perceived. This evidence can inform the strategies used to prevent and cope with financial emergencies and inform public policy to support household financial management

    Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children

    Get PDF
    Abstract Background Young children are at greatest risk for malaria-associated morbidity and mortality. The immune response of young children differs in fundamental ways from that of adults, and these differences likely contribute to the increased susceptibility of children to severe malaria and to their delayed development of immunity. Elevated levels of pro-inflammatory cytokines and chemokines in the peripheral blood during acute infection contribute to the control of parasitaemia, but are also responsible for much of the immunopathology seen during symptomatic disease. Clinical immunity to malaria may depend upon the ability to regulate these pro-inflammatory responses, possibly through mechanisms of immunologic tolerance. In order to explore the effect of age on the immune response to malaria and the development of clinical immunity, cytokines and chemokines were measured in the plasma of children at day 0 of an acute malaria episode and during convalescence. Results Younger children presenting with acute malaria exhibited much higher levels of TNF, IL2, and IL6, as well as increased Th1 associated chemokines IP10, MIG, and MCP1, compared to older children with acute malaria. Additionally, the regulatory cytokines IL10 and TNFRI were dramatically elevated in younger children compared to older children during acute infection, indicating that regulatory as well as pro-inflammatory cytokine responses are dampened in later childhood. Conclusions Together these data suggest that there is a profound blunting of the cytokine and chemokine response to malaria among older children residing in endemic settings, which may be due to repeated malaria exposure, intrinsic age-based differences in the immune response, or both

    Switchgrass nitrogen response and estimated production costs on diverse sites

    No full text
    Switchgrass (Panicum virgatum L.) has been the principal perennial herbaceous crop investigated for bioenergy production in North America given its high production potential, relatively low input requirements, and potential suitability for use on marginal lands. Few large trials have determined switchgrass yields at field scale on marginal lands, including analysis of production costs. Thus, a field-scale study was conducted to develop realistic yield and cost estimates for diverse regions of the USA. Objectives included measuring switchgrass response to fertility treatments (0, 56, and 112 kg N ha−1) and generating corresponding estimates of production costs for sites with diverse soil and climatic conditions. Trials occurred in Iowa, New York, Oklahoma, South Dakota, and Virginia, USA. Cultivars and management practices were site specific, and field-scale equipment was used for all management practices. Input costs were estimated using final harvest-year (2015) prices, and equipment operation costs were estimated with the MachData model (2015).Switchgrassyieldsgenerallywerebelowthosereportedelsewhere,averaging6.3Mgha1acrosssitesandtreatments.Establishmentstandpercentrangedfrom282015). Switchgrass yields generally were below those reported elsewhere, averaging 6.3 Mg ha−1 across sites and treatments. Establishment stand percent ranged from 28% to 76% and was linked to initial year production. No response to N was observed at any site in the first production year. In subsequent seasons, N generally increased yields on well-drained soils; however, responses to N were nil or negative on less well-drained soils. Greatest percent increases in response to 112 kg N ha−1 were 57% and 76% on well-drained South Dakota and Virginia sites, where breakeven prices to justify N applications were over 70 and $63 Mg−1, respectively. For some sites, typically promoted N application rates may be economically unjustified; it remains unknown whether a bioenergy industry can support the breakeven prices estimated for sites where N inputs had positive effects on switchgrass yield.This article is published as Fike, J. H., Pease, J. W., Owens, V. N., Farris, R. L., Hansen, J. L., Heaton, E. A., Hong, C. O., Mayton, H. S., Mitchell, R. B. and Viands, D. R. (2017), Switchgrass nitrogen response and estimated production costs on diverse sites. GCB Bioenergy, 9: 1526–1542. doi:10.1111/gcbb.12444. </p

    Switchgrass nitrogen response and estimated production costs on diverse sites

    Get PDF
    Switchgrass (Panicum virgatum L.) has been the principal perennial herbaceous crop investigated for bioenergy production in North America given its high production potential, relatively low input requirements, and potential suitability for use on marginal lands. Few large trials have determined switchgrass yields at field scale on marginal lands, including analysis of production costs. Thus, a field-scale study was conducted to develop realistic yield and cost estimates for diverse regions of the USA. Objectives included measuring switchgrass response to fertility treatments (0, 56, and 112 kg N ha-1) and generating corresponding estimates of production costs for sites with diverse soil and climatic conditions. Trials occurred in Iowa, New York, Oklahoma, South Dakota, and Virginia, USA. Cultivars and management practices were site specific, and field-scale equipment was used for all management practices. Input costs were estimated using final harvest-year (2015) prices, and equipment operation costs were estimated with the MachData model (2015).Switchgrassyieldsgenerallywerebelowthosereportedelsewhere,averaging6.3Mgha1acrosssitesandtreatments.Establishmentstandpercentrangedfrom282015). Switchgrass yields generally were below those reported elsewhere, averaging 6.3 Mg ha-1 across sites and treatments. Establishment stand percent ranged from 28% to 76% and was linked to initial year production. No response to N was observed at any site in the first production year. In subsequent seasons, N generally increased yields on well-drained soils; however, responses to N were nil or negative on less well-drained soils. Greatest percent increases in response to 112 kg N ha-1 were 57% and 76% on well-drained South Dakota and Virginia sites, where breakeven prices to justify N applications were over 70 and $63 Mg-1, respectively. For some sites, typically promoted N application rates may be economically unjustified; it remains unknown whether a bioenergy industry can support the breakeven prices estimated for sites where N inputs had positive effects on switchgrass yield

    Key environmental and production factors for understanding variation in switchgrass chemical attributes

    Get PDF
    Switchgrass (Panicum virgatum L.) is a promising feedstock for bioenergy and bioproducts; however, its inherent variability in chemical attributes creates challenges for uniform conversion efficiencies and product quality. It is necessary to understand the range of variation and factors (i.e., field management, environmental) influencing chemical attributes for process improvement and risk assessment. The objectives of this study were to (1) examine the impact of nitrogen fertilizer application rate, year, and location on switchgrass chemical attributes, (2) examine the relationships among chemical attributes, weather and soil data, and (3) develop models to predict chemical attributes using environmental factors. Switchgrass samples from a field study spanning four locations including upland cultivars, one location including a lowland cultivar, and between three and six harvest years were assessed for glucan, xylan, lignin, volatiles, carbon, nitrogen, and ash concentrations. Using variance estimation, location/cultivar, nitrogen application rate, and year explained 65%–96% of the variation for switchgrass chemical attributes. Location/cultivar × year interaction was a significant factor for all chemical attributes indicating environmental-based influences. Nitrogen rate was less influential. Production variables and environmental conditions occurring during the switchgrass field trials were used to successfully predict chemical attributes using linear regression models. Upland switchgrass results highlight the complexity in plant responses to growing conditions because all production and environmental variables had strong relationships with one or more chemical attributes. Lowland switchgrass was limited to observations of year-to-year environmental variability and nitrogen application rate. All explanatory variable categories were important for lowland switchgrass models but stand age and precipitation relationships were particularly strong. The relationships found in this study can be used to understand spatial and temporal variation in switchgrass chemical attributes. The ability to predict chemical attributes critical for conversion processes in a geospatial/temporal manner would provide state-of-the-art knowledge for risk assessment in the bioenergy and bioproducts industry.This article is published as Hoover, Amber N., Rachel Emerson, Marnie Cortez, Vance Owens, Ed Wolfrum, Courtney Payne, John Fike et al. "Key environmental and production factors for understanding variation in switchgrass chemical attributes." GCB Bioenergy (2022). doi:10.1111/gcbb.12942. Posted with permission. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited
    corecore